Global Carbocisteine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.

In the last several years, Global market of Carbocisteine developed steady, with an average growth rate of 5.2%. In 2016, Global Revenue of Carbocisteine is nearly 35 M USD; the actual production is about 1600 MT.

The classification of Carbocisteine includes 98.5% and >98.5%, and the sales proportion of >98.5% in 2016 is about 76.2%.

Carbocisteine is widely used to make drugs, the formal of drugs include Oral Solution, Tablet & Capsule and Other. The most proportion of Carbocisteine formal is Tablet & Capsule and the proportion in 2016 is about 74%.

China is the largest supplier of Carbocisteine, with a revenue market share nearly 46% in 2016. India is the second largest supplier of Carbocisteine, enjoying revenue market share nearly 25% in 2016.

Europe is the largest consumption place, with a consumption market share nearly 33% in 2016. Following Europe, China is the second largest consumption place with the consumption market share of 26%.

Market competition is not intense. Wuhan Grand Hoyo, Moehs Iberica, Afton Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Carbocisteine Market
In 2019, the global Carbocisteine market size was US$ 48 million and it is expected to reach US$ 64 million by the end of 2026, with a CAGR of 4.1% during 2021-2026.
Global Carbocisteine Scope and Market Size
Carbocisteine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Carbocisteine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Carbocisteine market is segmented into
0.985
>98.5%

Segment by Application, the Carbocisteine market is segmented into
Oral Solution
Tablet & Capsule
Others

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Carbocisteine Market Share Analysis
Carbocisteine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Carbocisteine product introduction, recent developments, Carbocisteine sales by region, type, application and by sales channel.

The major companies include:
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
...